A three-layer structure: the company holds the method, the project builds the evidence, and the product delivers the experience. Evidence takes precedence over product opinion, and the same structure is applied to the next condition.
| Layer | Owns | Speaks to | Definition of success |
|---|---|---|---|
| Root to Life company | Mission · entity · capital · IP · method · data governance · brand system | Investors · partners · government | Build a structure that repeats across diseases |
| Kidney Bloom project | Research · evidence · design principles · regulatory judgment · public content | Clinicians · researchers · policy | Evidence beats product opinion |
| My Beanie product | User experience · records · community | Patients · caregivers | It gets opened every day |
The expansion roadmap is My Beanie Kidney (now) → Heart / Sugar (2028) → Air (2029). The mascot, record engine, method and brand are retained; only the disease area changes. Project-layer names for later diseases (Heart Bloom · Sugar Bloom · Air Bloom) are working titles.
The cycle is measured by The Self-Explanation Index; a cycle succeeds when users reach LV2.
Collect scenes that repeat in patient and caregiver interviews, communities, and clinics
Verify against clinical guidelines, literature, and statistics. No evidence, no next step
Translate into one cell of the 3×5 grid. No cell, no feature
Judge by gate conditions. Results and failures feed back into 01
Interpretation ranges and wording for eGFR, creatinine, proteinuria / alignment with KDIGO and KSN guidelines / comorbidity interactions
Rules for translating SDT's three needs into features / notification volume vs. churn / sharing that never becomes surveillance
Korean rare-disease copay relief, kidney disability registration, chronic-care reimbursement / MFDS wellness boundary / FDA General Wellness and CDS
FHIR R4 · US Core 3.1.1 / Apple Health Records requirements (SMART on FHIR, 8 required resources) / consent design
| Format | What it is | Where it is used |
|---|---|---|
| Evidence Note | Sourced claim | Source for every product string and public content |
| Design Principle | Cell definition | Defines each cell of the 3×5 grid |
| Regulatory Memo | Regulatory judgment | Basis for approving or shelving a feature |
| Metric Spec | Metric definition | Self-Explanation levels and gate conditions |
| Public Content | Public material | Instagram carousels · case studies · kidneybloom.com |
Same engine, different disease. What ports as-is, and what must be rebuilt.
Index · grid · gates · four-step R&D
Tone · color · mascot · content formats
Consented longitudinal records · FHIR structure. Data itself is disease-specific
Advisors, pilot sites, and communities must be rebuilt per disease
The founder trained in visual communication design and built the design system and template architecture for the investment banking division at Samsung Securities. Compressing complex financial information into decision-ready form is the same approach My Beanie applies to health records. Research background in cognitive load theory and dual-process theory; the product started from first-hand experience of kidney disease management.
Content review and first patient touchpoints. The current priority.
Interviews and MVP testing with 20–30 pre-dialysis CKD patients.
To validate Lanes A and B within 12 months.
Size and timing decided after Phase 2 retention data is available.
Confidential materials (business plan, product design, metrics) are shared only after a non-disclosure agreement (NDA). A first meeting works within what is published on this site.
Information published on this site is distinguished from materials shared under a non-disclosure agreement.
Copy, screen layouts, illustrations (Beanie), brands, code and the report and mirror-card formats are works of Root to Life. Reproduction, distribution, adaptation or imitation without prior written consent is prohibited; key works are registered with the Korea Copyright Commission.
Business plans, product design, roadmap, metrics and revenue models are shared after a non-disclosure agreement is signed. Content explained verbally or on screen in a meeting is protected in the same way. A first meeting is held within the public scope.
Unauthorized use of ideas or business information obtained during partnership or investment review may constitute unfair competition (idea misappropriation) under Korea's Unfair Competition Prevention Act. Materials are shared on that basis.
Full text in the Terms of Use, section 3 (copyright) and section 5 (business materials and confidentiality). For quotation, press or research use, please contact hello@kidneybloom.com in advance.
Before speed of shipping, the rule for what never goes on screen was set. Three principles apply to every screen and every line of copy.
Which patient and which moment are defined first. Features are built only from verified scenes, and real-user feedback sets the priorities for the next version.
The eGFR formula, the body-signal list, meal caution tags and dialysis log items are finalized under nephrologist advice and review. No claim goes on screen without an evidence note.
No server or account to begin with. The app never diagnoses or alarms; judgment rests with the care team. Server and sign-in are introduced together with a consent framework.
Current stage: MVP in real-user validation, pre-incorporation. Governance and IP structure are a draft, to be finalized on incorporation with legal counsel. All figures on this site are from 2025–2026 public sources; financial projections will be written only after real-user data exists.